- PR Newswire•2 months ago
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, June 21, 2016 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (OTC: ALXA, "Alexza") and Grupo Ferrer Internacional, S.A. ("Ferrer") today announced ...
- Capital Cube•3 months ago
Click here to see latest analysisAlexza Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Alexza Pharmaceuticals, Inc. – DURECT Corporation, Aradigm Corporation, BioDelivery Sciences International, Inc., Titan Pharmaceuticals, Inc., Paratek Pharmaceuticals Inc, Vanda Pharmaceuticals Inc., Nektar Therapeutics, Teva Pharmaceutical Industries Limited Sponsored […] (Read more...) The post Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 appeared first on CapitalCube.
- Business Wire•3 months agoINVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Alexza Pharmaceuticals, Inc.
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52wk Range||undefined - undefined|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|